| | |

First-Line Chemotherapy for Peritoneal Mesothelioma

ByAlex Strauss
chemotherapy for peritoneal mesothelioma

The same drugs doctors use to treat pleural mesothelioma can provide effective chemotherapy for peritoneal mesothelioma, too.

Japanese researchers reviewed the cases of 29 peritoneal mesothelioma patients. These patients had first-line treatment with cisplatin and pemetrexed between 2001 and 2016.

The results suggest these drugs are safe and potent chemotherapy for peritoneal mesothelioma. The finding may help doctors and patients make better treatment decisions.

Treating Malignant Mesothelioma

Malignant mesothelioma is a membrane cancer. It usually occurs in one of two places. About 80 percent of mesothelioma tumors arise on the membrane that surrounds the lungs (the pleura). This is called pleural mesothelioma. 

About 20 percent of the 2,500 cases of mesothelioma diagnosed in the US each year are peritoneal. Peritoneal mesothelioma arises on the membrane that lines the abdomen (the peritoneum). 

The first-line treatment usually recommended for peritoneal mesothelioma is cytoreductive surgery (CRS). This is often followed by a rinse of heated chemotherapy drugs (HIPEC). CRS + HIPEC has improved the outlook for many people with peritoneal mesothelioma.

But not all patients are candidates for this type of chemotherapy for peritoneal mesothelioma. Some tumors are too large or widespread to remove. Patients who are elderly, fragile, or have other underlying medical conditions may also have to forego surgery. 

For these patients, systemic treatment may be the best option.

Types of Chemotherapy for Peritoneal Mesothelioma

HIPEC is a localized chemotherapy for peritoneal mesothelioma. It is administered at the location of the resected mesothelioma tumor while the patient is still on the operating table. 

Systemic chemotherapy for peritoneal mesothelioma goes all throughout the body. It is administered via infusion.   

Right now, doctors do not agree on the best drug combination for peritoneal mesothelioma patients who are not having surgery. One option is to use the same combination doctors use for pleural mesothelioma. Pleura mesothelioma patients usually receive pemetrexed (Alimta) and cisplatin.

In the new study, the Japanese team analyzed the outcomes of this combination of chemotherapy for peritoneal mesothelioma. 

Alimta + Cisplatin Recommended for Peritoneal Mesothelioma

The study included 29 peritoneal mesothelioma patients who received cisplatin and Alimta. It took a median of 7.1 months for their tumors to start growing again after treatment. Their median overall survival was 15.4 months. 

Thirty-eight percent of patients with measurable tumors responded to Alimta/cisplatin chemotherapy for peritoneal mesothelioma.

Twenty-one percent of these patients had a serious drop in their disease-fighting white blood cell levels. But none of the patients died as a result of the treatment. 

The Japanese researchers conclude that the combination of cisplatin and Alimta “can be recommended” as first-line treatment for peritoneal mesothelioma when surgery is not an option.

Source:

Nagata, Y, et al, “Efficacy and safety of pemetrexed plus cisplatin as first-line chemotherapy in advanced malignant peritoneal mesothelioma”, July 9, 2019, Japanese Journal of Clinical Oncology, Epub ahead of print, https://academic.oup.com/jjco/advance-article-abstract/doi/10.1093/jjco/hyz104/5530220?redirectedFrom=fulltext

Similar Posts

Doctors Describe "Concrete Therapeutic Approach" for Mesothelioma
| |

Doctors Describe "Concrete Therapeutic Approach" for Mesothelioma

ByAlex Strauss

A team of medical researchers in Italy have achieved what they are calling “excellent” tumor control and survival results in malignant pleural mesothelioma patients using a combination of surgery, chemotherapy, and radiotherapy. Caused by exposure to asbestos, mesothelioma typically spreads quickly across the lung-encasing membrane called the pleura. There is no known cure but treatments are improving. In the current prospective study, 20 malignant pleural mesothelioma patients underwent radical pleurectomy/decortication followed by high doses of radiation. After surgeons removed as much of the visible mesothelioma tumor and surrounding tissue as possible, patients received 50Gy of radiation to the effected side of their chest, delivered in 25 fractions. Regions of particular concern for mesothelioma regrowth got an extra radiation “boost” to…

Mesothelioma Still Rising Despite Ban in Ireland
|

Mesothelioma Still Rising Despite Ban in Ireland

ByAlex Strauss

A study in Ireland confirms that it can take many years for a ban on asbestos to have a measurable impact on a country’s rates of malignant mesothelioma. Mesothelioma is the most serious of a list of diseases – including lung cancer, pleural plaques, asbestosis, and others – linked with exposure to asbestos dust. Affecting the linings around the lungs and other organs, mesothelioma is often resistant to most cancer treatments and may be fatal within a year of diagnosis. According to the International Ban Asbestos Secretariat, Ireland is one of 55 countries that have enacted some type of asbestos ban. However, although Ireland banned asbestos in 2000, a new study published in Cancer Epidemiology shows that incidence of the…

Does Radiotherapy Reduce Mesothelioma Pain?
| |

Does Radiotherapy Reduce Mesothelioma Pain?

ByAlex Strauss

A new study says there is not enough evidence to support the use of radiotherapy for the treatment of pain associated with malignant pleural mesothelioma. Researchers at the University of Edinburgh in Scotland reviewed a range of past studies on mesothelioma pain and radiotherapy by searching databases that date back as far as 1974. To be eligible to be included in their review, the study had to focus on malignant pleural mesothelioma and radiotherapy given “with the intent of improving pain”. The study also had to report doses and fractionation of the radiotherapy and how the pain responded. In all, the researchers found eight studies on mesothelioma pain and radiotherapy that met the criteria. Two of the studies were prospective…

Website Aims to Protect Homeowners from Mesothelioma
|

Website Aims to Protect Homeowners from Mesothelioma

ByAlex Strauss

Australia’s Cancer Council is trying to educate home renovators about their risk for mesothelioma with a new e-learning course. Australia has one of the highest per capita rates of mesothelioma in the world, largely because of several asbestos mining operations that were once located there. Although asbestos has been banned from building products in Australia since 1989, asbestos-linked diseases like mesothelioma, lung cancer, and asbestosis continue to pose a serious health concern. While mesothelioma has traditionally occurred among people exposed to asbestos on the job, Australia is now bracing for another “wave” of mesothelioma victims among homeowners who encounter asbestos while doing their own renovation projects. Cancer Council Australia has launched “kNOw asbestos in your home” in an effort to…

Radiotherapy for Mesothelioma: Better But Still Limited
| |

Radiotherapy for Mesothelioma: Better But Still Limited

ByAlex Strauss

A form of highly-targeted radiation therapy for mesothelioma is better than it used to be, but is still risky. That is the message of a recent article on intensity-modulated radiation therapy (IMRT) in Seminars in Thoracic and Cardiovascular Surgery. Author Kenneth E. Rosenzweig, MD, a Radiation Oncologist with Mount Sinai Hospital in New York, reviewed recent studies on IMRT and mesothelioma. He concludes that, while the “troubling toxicity” associated with IMRT when it was first introduced has not been entirely eliminated, the fact that clinicians now have more experience with it is making a positive difference for mesothelioma patients. Before targeted therapies like IMRT were available, high-dose radiation was not usually a feasible option for mesothelioma since the irregular shape…

Mesothelioma Nurses Ready for New Cases in Australia
| | |

Mesothelioma Nurses Ready for New Cases in Australia

ByAlex Strauss

Australia is bracing for an expected new wave of mesothelioma cases in the next decade and the Lung Foundation of Australia is taking action now to get ready. The Foundation has paid for ten nurses from around the country to receive specialized training in helping patients and families cope with mesothelioma. The nurses, who have recently completed the training, are now equipped to lead treatment planning for these complex cancer patients and to help other nurses do the same. Pleural mesothelioma is an aggressive cancer that occurs in the lining around the lungs. It is caused by exposure to asbestos dust, a toxin that was once alarmingly prevalent in Australia where it was mined and heavily used in construction. Because…